Restless legs syndrome among Saudi end-stage renal disease patients on hemodialysis

References

1. ↵
   1. American Academy of Sleep Medicine

   (2005) The International Classification of Sleep Disorders (American Academy of Sleep Medicine, Chicago (IL)), 2nd ed.

   Google Scholar
2. ↵
   1. Allen RP,
   2. Picchietti D,
   3. Hening WA,
   4. Trenkwalder C,
   5. Walters AS,
   6. Montplaisi J,
   7. et al.

   (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101–119.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
3. ↵
   1. Ohayon MM,
   2. O’Hara R,
   3. Vitiello MV

   (2012) Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev 16:283–295.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
4. ↵
   1. Murtagh FE,
   2. Addington-Hall J,
   3. Higginson IJ

   (2007) The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 14:82–99.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
5. ↵
   1. Kawauchi A,
   2. Inoue Y,
   3. Hashimoto T,
   4. Tachibana N,
   5. Shirakawa S,
   6. Mizutani Y,
   7. et al.

   (2006) Restless legs syndrome in hemodialysis patients: health-related quality of life and laboratory data analysis. Clin Nephrol 66:440–446.

   OpenUrlPubMedWeb of ScienceGoogle Scholar
6. ↵
   1. Nikić PM,
   2. Andrić BR,
   3. Stojanović-Stanojević M,
   4. Dordević V,
   5. Petrović D,
   6. Stojimirović BB

   (2007) Restless legs syndrome prevalence in patients on chronic hemodialysis in central Serbia. Vojnosanit Pregl 64:129–134.

   OpenUrlPubMedGoogle Scholar
7. ↵
   1. Goffredo Filho GS,
   2. Gorini CC,
   3. Purysko AS,
   4. Silva HC,
   5. Elias IE

   (2003) Restless legs syndrome in patients on chronic hemodialysis in a Brazilian city: frequency, biochemical findings and comorbidities. Arq Neuropsiquiatr 61:723–727.

   OpenUrlPubMedGoogle Scholar
8. ↵
   1. Salman SM

   (2011) Restless legs syndrome in patients on hemodialysis. Saudi J Kidney Dis Transpl 22:368–372.

   OpenUrlPubMedGoogle Scholar
9. ↵
   1. Al-Jahdali HH,
   2. Al-Qadhi WA,
   3. Khogeer HA,
   4. Al-Hejaili FF,
   5. Al-Ghamdi SM,
   6. Al Sayyari AA

   (2009) Restless legs syndrome in patients on dialysis. Saudi J Kidney Dis Transpl 20:378–385.

   OpenUrlPubMedGoogle Scholar
10. ↵
    1. BaHammam A,
    2. Al-shahrani K,
    3. Al-zahrani S,
    4. Al-shammari A,
    5. Al-Amri N,
    6. Sharif M

    (2011) The prevalence of restless legs syndrome in adult Saudis attending primary health care. Gen Hosp Psychiatry 33:102–106.

    OpenUrlPubMedGoogle Scholar
11. ↵
    1. Sherman RA,
    2. Cody RP,
    3. Rogers ME,
    4. Solanchick JC

    (1995) Accuracy of the urea reduction ratio in predicting dialysis delivery. Kidney Int 47:319–321.

    OpenUrlPubMedWeb of ScienceGoogle Scholar
12. ↵
    1. Johns MW,
    2. Hocking B

    (1997) Daytime sleepiness and sleep habits of Australian workers. Sleep 20:844–949.

    OpenUrlPubMedWeb of ScienceGoogle Scholar
13. ↵
    1. Walters AS,
    2. LeBrocq C,
    3. Dhar A,
    4. Hening W,
    5. Rosen R,
    6. Allen RP,
    7. et al.

    (2003) Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. International Restless Legs Syndrome Study Group. Sleep Med 4:121–132.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
14. ↵
    1. Ahmadi N,
    2. Chung SA,
    3. Gibbs A,
    4. Shapiro C

    (2008) The Berlin questionnaire for sleep apnea in a sleep clinic population: relationship to polysomnographic measurement of respiratory disturbance. Sleep Breath 12:39–45.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
15. ↵
    1. Winkelmann J,
    2. Schormair B,
    3. Lichtner P,
    4. Ripke S,
    5. Xiong L,
    6. Jalilzadeh S,
    7. et al.

    (2007) Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39:1000–1006.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
16. ↵
    1. Allen RP,
    2. Walters AS,
    3. Montplaisir J,
    4. Hening W,
    5. Myers A,
    6. Bell TJ,
    7. et al.

    (2005) Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 165:1286–1292.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
17. ↵
    1. La Manna G,
    2. Pizza F,
    3. Persici E,
    4. et al.

    (2011) Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transplant 26:1976–1983.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
18. ↵
    1. Kim M,
    2. Kwon M,
    3. Lim S,
    4. Kim S,
    5. Lee J,
    6. Nam H

    (2008) Restless Legs Syndrome in Patients on Hemodialysis: Symptom Severity and Risk Factors. J Clin Neurol 4:153–157.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
19. ↵
    1. Miyamoto M,
    2. Miyamoto T,
    3. Iwanami M,
    4. Suzuki K,
    5. Hirata K

    (2009) Pathophysiology of restless legs syndrome. Brain Nerve 61:523–532.

    OpenUrlPubMedGoogle Scholar
20. ↵
    1. Gigli GL,
    2. Adorati M,
    3. Dolso P,
    4. Piani A,
    5. Valente M,
    6. Brotini S,
    7. et al.

    (2004) Restless legs syndrome in end-stage renal disease. Sleep Med 5:309–315.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
21. ↵
    1. Winter AC,
    2. Berger K,
    3. Glynn RJ,
    4. Buring JE,
    5. Gaziano JM,
    6. Schürks M,
    7. et al.

    (2013) Vascular risk factors, cardiovascular disease, and restless legs syndrome in men. Am J Med 126:228–235.

    OpenUrlGoogle Scholar
22. ↵
    1. Winter AC,
    2. Schürks M,
    3. Glynn RJ,
    4. Buring JE,
    5. Gaziano JM,
    6. Berger K,
    7. et al.

    (2013) Vascular risk factors, cardiovascular disease, and restless legs syndrome in women. Am J Med 126:220–227.

    OpenUrlPubMedGoogle Scholar
23. ↵
    1. Collado-Seidel V,
    2. Kohnen R,
    3. Samtleben W,
    4. Hillebrand GF,
    5. Oertel WH,
    6. Trenkwalder C

    (1998) Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 31:324–328.

    OpenUrlPubMedWeb of ScienceGoogle Scholar
24. ↵
    1. Gao X,
    2. Schwarzschild MA,
    3. Wang H,
    4. Ascherio A

    (2009) Obesity and restless legs syndrome in men and women. Neurology 72:1255–1261.

    OpenUrlCrossRefGoogle Scholar
25. 1. Ohayon MM,
    2. Roth T

    (2002) Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 53:547–554.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
26. ↵
    1. Kim J,
    2. Choi C,
    3. Shin K,
    4. Yi H,
    5. Park M,
    6. Cho N,
    7. et al.

    (2005) Prevalence of restless legs syndrome and associated factors in the Korean adult population: the Korean Health and Genome Study. Psychiatry Clin Neurosci 59:350–353.

    OpenUrlPubMedGoogle Scholar
27. ↵
    1. Wang GJ,
    2. Volkow ND,
    3. Logan J,
    4. Pappas NR,
    5. Wong CT,
    6. Zhu W,
    7. et al.

    (2001) Brain dopamine and obesity. Lancet 357:354–357.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
28. 1. Lee J,
    2. Nicholl DD,
    3. Ahmed SB,
    4. et al.

    (2013) The prevalence of restless legs syndrome across the full spectrum of kidney disease. J Clin Sleep Med 9:455–459.

    OpenUrlPubMedGoogle Scholar
29. ↵
    1. Wang J,
    2. O’Reilly B,
    3. Venkataraman R,
    4. Mysliwiec V,
    5. Mysliwiec A

    (2009) Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study. Sleep Med 10:973–975.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
30. ↵
    1. Sloand JA,
    2. Shelly MA,
    3. Feigin A,
    4. Bernstein P,
    5. Monk RD

    (2004) A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. Am J Kidney Dis 43:663–670.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
31. ↵
    1. Balaban H,
    2. Yıldız ÖK,
    3. Çil G,
    4. Şentürk İA,
    5. Erselcan T,
    6. Bolayır E,
    7. et al.

    (2012) Serum 25-hydroxyvitamin D levels in restless legs syndrome patients. Sleep Med 13:953–957.

    OpenUrlPubMedGoogle Scholar
32. ↵
    1. Giannaki CD,
    2. Sakkas GK,
    3. Karatzaferi C,
    4. Hadjigeorgiou GM,
    5. Lavdas E,
    6. Liakopoulos V,
    7. et al.

    (2011) Evidence of increased muscle atrophy and impaired quality of life parameters in patients with uremic restless legs syndrome. PLoS One 6:e25180.

    OpenUrlCrossRefPubMedGoogle Scholar
33. ↵
    1. Ceglia L

    (2009) Vitamin D and Its Role in Skeletal Muscle. Curr Opin Clin Nutr Metab Care 12:628–633.

    OpenUrlCrossRefPubMedGoogle Scholar
34. ↵
    1. Wali S,
    2. Shukr A,
    3. Boudal A,
    4. Alsaiari A,
    5. Krayem A

    (2014) The effect of vitamin D supplements on the severity of restless legs syndrome. Sleep & Breathing 23:Epub ahead of print.

    Google Scholar
35. 1. Takaki J,
    2. Nishi T,
    3. Nangaku M,
    4. Shimoyama H,
    5. Inada T,
    6. Matsuyama N,
    7. et al.

    (2003) Clinical and psychological aspects of restless legs syndrome in uremic patients on hemodialysis. Am J Kidney Dis 41:833–839.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
36. 1. Siddiqui S,
    2. Kavanagh D,
    3. Traynor J,
    4. Mak M,
    5. Deighan C,
    6. Geddes C

    (2005) Risk factors for restless legs syndrome in dialysis patients. Nephron 101:c155–c160.

    OpenUrlGoogle Scholar
37. 1. Sabry AA,
    2. Abo-Zenah H,
    3. Wafa E,
    4. Mahmoud K,
    5. El-Dahshan K,
    6. Hassan A,
    7. et al.

    (2010) Sleep disorders in hemodialysis patients. Saudi J Kidney Dis Transpl 21:300–305.

    OpenUrlPubMedGoogle Scholar
38. 1. Araujo SM,
    2. de Bruin VM,
    3. Nepomuceno LA,
    4. Maximo ML,
    5. Daher Ede F,
    6. Correia Ferrer DP,
    7. et al.

    (2010) Restless legs syndrome in end-stage renal disease: Clinical characteristics and associated morbidities. Sleep Med 11:785–790.

    OpenUrlCrossRefPubMedGoogle Scholar
39. 1. Tuncel DL,
    2. Orhan FO,
    3. Sayarlioglu H,
    4. Isık IO,
    5. Utku U,
    6. Dinc A

    (2011) Restless legs syndrome in hemodialysis patients: association with depression and quality of life. Sleep Breath 15:311–315.

    OpenUrlPubMedGoogle Scholar
40. 1. Kutner NG,
    2. Zhang R,
    3. Szczech LA,
    4. Bliwise DL

    (2012) Restless legs syndrome reported by incident hemodialysis patients: is treatment time of day relevant? Nephrology 17:783–784.

    OpenUrlPubMedGoogle Scholar
41. 1. Stefanidis I,
    2. Vanias A,
    3. Dardiotis E,
    4. Giannaki CD,
    5. Gourli P,
    6. Papadopoulou D,
    7. et al.

    (2013) Restless legs syndrome in hemodialysis patients: an epidemiologic survey in Greece. Sleep Med 14:1381–1386.

    OpenUrlGoogle Scholar
42. 1. Lin CH,
    2. Wu VC,
    3. Li WY,
    4. Sy HN,
    5. Wu SL,
    6. Chang CC,
    7. et al.

    (2013) Restless legs syndrome in end-stage renal disease: a multicenter study in Taiwan. Eur J Neurol 20:1025–1031.

    OpenUrlGoogle Scholar